Transdermal Estradiol/Norethisterone

@article{Wiseman1994TransdermalE,
  title={Transdermal Estradiol/Norethisterone},
  author={L. Wiseman and D. McTavish},
  journal={Drugs & Aging},
  year={1994},
  volume={4},
  pages={238-256}
}
  • L. Wiseman, D. McTavish
  • Published 1994
  • Medicine
  • Drugs & Aging
  • SummarySynopsisThe combined transdermal estradiol/norethisterone therapeutic system is designed to deliver both estradiol and norethisterone into the systemic circulation at a constant rate for up to 4 days when affixed to the skin. Transdermal administration avoids hepatic first- pass metabolism, allowing therapeutic concentrations of the progestogen and estrogen to be maintained in postmenopausal women following low dose administration. Transdermal norethisterone does not appear to alter the… CONTINUE READING
    27 Citations
    The influence of medroxyprogesterone acetate on the effects of transdermal oestradiol replacement therapy on plasma lipids.
    • 5
    Effect of an estradiol gel with monthly or quarterly progestogen on menopausal symptoms and bleeding
    • 5
    Pharmacology of estrogens and progestogens: influence of different routes of administration
    • H. Kuhl
    • Medicine
    • Climacteric : the journal of the International Menopause Society
    • 2005
    • 436
    • PDF
    A current perspective into young female sex hormone replacement: a review
    • 1

    References

    SHOWING 1-10 OF 75 REFERENCES
    Transdermal Estradiol
    • 37
    Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins.
    • 181
    Plasma lipid and lipoprotein effects of transdermal administration of estradiol and estradiol/norethisterone acetate.
    • 15
    Estrogen replacement therapy by transdermal estradiol administration.
    • 127